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Purpose: To evaluate the safety and efficiency of the
Ultrasound (US)-guided large needle core biopsy of axilla
lymph nodes. Materials and Methods: From March 2004 to
September 2005, 31 patients underwent the US-guided core
biopsy for axilla lymph nodes. Twenty five lesions out of
31 were detected during breast US, and 6 of 31 cases were
palpable. Lymph nodes were classified based on their shape
and cortical morphology. The core biopsy of axilla lymph
nodes was performed on suspicious lymph nodes found
during breast ultrasonography to find out whether the
patients had a history of breast cancer or not. Among the
31 patients, 16 patients were associated with breast cancer.
The lesion sizes varied from 0.6 cm to 3.3 cm (mean = 1.59
± 0.76 cm). US-guided core biopsies were performed with
14 G needles with an automated biopsy gun. Total 3 or 5
specimens were obtained. Results: Among the 31 cases of
axilla lymph nodes core biopsies, 11 cases showed malig-
nant pathology. Seven out of 11 cases were metastatic
lymph nodes from breast cancer; 2 cases were from primary
unknown and 2 cases from lymphomas. On the other hand,
20 histopathologic results of axilla lesions were benign:
subacute necrotizing lymphadenitis (n = 2), dermatopathic
lymphadenitis (n = 1), reactive hyperplasia (n = 10) and free
of carcinoma (n = 7). Conclusion: The US-guided large
needle core biopsy of axilla lesions is safe and effective for
the pathological evaluation. The core biopsy is believed to
be easy to perform if suspicious lymph nodes or mass
lesions are found in the axilla.
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lymph nodes
INTRODUCTION
Pathologic lesions in the axilla develop in a wide
range of disease. Among them, lymph node
abnormality is the most common pathologic
finding. The causes of the lymph node abnormality
also vary, ranging from benign inflammatory
disorders to malignant reasons.1 Most cases of
lymphadenopathies detected through imaging
examinations are not palpable, and pretreatment
pathologic diagnoses are demanded. Fine needle
aspiration cytology under the ultrasound guidance
is commonly employed and has been reported to
be the easiest and accurate method.2-4 Jaffer et al.
reported the sensitivity and the specificity of the
ultrasound-guided fine-needle aspiration cytology
(US-guided FNAC) as high as 100%,5 and another
report presented that the overall sensitivity of the
US-guided FNAC was 86.4%, the specificity was
100%, and the diagnostic accuracy was 79%.3
However, the false negative rate of FNAC was
11.6%, and 8 of 38 patients (21.0%) who did not
receive preoperative chemotherapy because of
false negative rate.3 Biopsies with 18-gauge needle
of the small series have been reported, and several
studies have recently reported about the ultra-
sound-guided larger 14-gauge needle core biopsy
of the axilla lesions.6,7 An imaging-guided core
biopsy has higher sensitivity than FNAC for as-
sessing breast lesions, and the trend would be
similar to the US-guided core biopsy of the axilla.
The purpose of this study was to investigate the
usefulness and safety of the US-guided core
biopsy of axilla lesions and to evaluate the benefit
of preoperative diagnosis of the nodal staging in
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breast cancers.
MATERIALS AND METHODS
From March 2004 to September 2005, 31 patients
with suspicious lymph nodes in the axilla, visible
in ultrasound, underwent the US-guided core
biopsy. A waiver of informed consent from
institutional review board before our study was
obtained. All patients underwent clinical examina-
tions and mammogram before their ultrasound
examinations. The mean age of patients was 45 ±
15.7 (from 31 to 64 years). Among 31 patients, 6
patients complained of a palpable mass in the
axilla, and suspicious lymph nodes were incid-
entally found in the remaining 25 patients during
the breast ultrasound. Abnormal Lymph nodes
were categorized according to their shape and the
morphology of the cortex and hilum as follows: 1)
there was the length to width ratio (l/w) with less
than 1.5, since l/w higher than 2.0 indicates that
the node is benign;6 2) The cortex of the nodes
was concentrically or eccentrically thickened to
more than 2 mm;6 3) Compression of the hilus and
especially the absence of the hilus are thought to
be highly suggestive of malignancy. If the axillary
lymph nodes exhibited any of abnormal findings
mentioned above, they were defined as suspi-
cious.
Sixteen patients were associated with breast
cancer, and 15 other patients had no lesion in the
breast. Among 16 breast cancer patients, 13 cases
had a previous history of breast cancer. Their
follow-up breast ultrasound revealed suspicious
lymph nodes in the axilla without breast lesions.
Seven out of 13 cases were contralateral lymph
node, and 6 cases were ipsilateral lymph node in
the axilla. Remaining 3 out of 16 patients were
diagnosed of BI-RADS (Breast Imaging Reporting
and Data System) category 5 lesions in the breast
and suspicious lymph nodes in the axilla at the
same tim: Those were seen at ipsilateral in one
case and contralateral in two cases. The TNM
stages of the breast cancer patients were stage I
(n = 0), IIA (n = 2), IIB (n = 6), IIIA (n = 3), IIIB (n =
2), and IV (n = 0) in previously diagnosed patients,
and stage IIB (n = 2) and IIIA (n = 1) in currently
diagnosed patients.
Ultrasound scanning of the axilla and breast
was carried out with a 10 - 12 MHz transducer
with HDI 5000 machine (Advanced Technology
Laboratories, Bothell, WA, USA).
The core biopsies of nonpalpable axilla lymph
nodes were performed on suspicious axilla lymph
nodes which were found during breast ultra-
sound. The contralateral or ipsilateral suspicious
axilla lymph nodes in patients with ACR BI-RADS
category 4 or 5 lesion in their breast and those
patients whose breast cancer had previously been
treated were also indicated. The lesion size was
0.6 cm to 3.3 cm (mean = 1.59 ± 0.76 cm). All bio-
psies were ultrasound-guided with a free hand
approach. Fourteen-gauge (2.1 mm) needles were
used with an automatic biopsy gun, and 15 mm
shooting was selected (Bard-Magnum Biopsy
Instrument, Covington, GA, USA). The number of
needle pass was 3 to 5. For the evaluation of any
post-procedural complications at the site of the
biopsy, all patients underwent clinical examinations
a few days after the biopsy.
For the patients who underwent axillary
dissection (n = 4), the number and size of the
dissected and metastatic nodes were reported. The
close follow-up was conducted with ultrasound in
patients treated with chemotheraphy or radio-
theraphy. The cases of benign pathology were
examined by ultrasound over the next 2 years.
RESULTS
Among 31 cases of axilla lymph nodes biopsy,
11 cases showed malignant and 20 cases benign
pathology. Seven of the 11 malignant nodes were
metastatic lymph nodes from breast cancer; 2
were from unknown primary, and remaining 2
from lymphoma. Twenty benign histopathologic
results were as follows: subacute necrotizing
lymphadenitis in 2, dermatopathic lymphadenitis
in 1, and reactive hyperplasia in 10 and free of
carcinomas in 7 (Table 1). Among them, 8 patients
had a previous history of breast cancer, and one
patient was diagnosed with breast cancer at the
current examination. There was no complication
during and after the core biopsy procedure, and
plenty of specimens were obtained even in a small
lesion less than 1 cm in size.
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Out of 7 patients with breast cancer, 5 patients
had a previous history of breast cancer. Only one
patient showed an ipsilateral lymph node metastasis
and 4 patients demonstrated a contralateral lymph
nodes metastasis. All 5 patients received chemo-
theraphy, and 2 patients had a systemic metastasis,
such as pericardium and supraclavicular lymph
nodes metastases or a lung metastasis. One
patient underwent contralateral axillary dissec-
tion, and metastasis in 5 out of 19 dissected lymph
Table 1. Histopathologic Results of Large Needle Core Biopsies of Axilla Lesions
Histopathologic findings Patients (n)
Metastasis of breast cancer 7
Metastasis, primary unknown 2
B-cell lymphoma 1
Hodgkin's lymphoma 1
Subacute necrotizing lymphadenitis 2
Dermatopathic lymphadenitis 1
Reactive hyperplasia 10
Free of carcinoma 7
Total 31
Fig 1. A 51-year-old woman with a metastatic lymph node in the right axilla. (A) The mediolateral oblique view of
mammography shows an enlarged high density lymph node in the right axilla without mass or microcalcifications in the
right breast. (B) Ultrasonography revealed a 1.48 × 0.71 cm sized hypoechoic lymph node in the right axilla, showing loss
of a fatty hilum. (C) The ultrasound guided 14-gauge automated core biopsy was performed at the axilla lymph node,
and the real time visualization of the needle was achievable. (D) A large needle (14-gauge) lymph node specimen (H&E
stain, × 20) shows the cores of metastatic carcinoma occupying almost the entire biopsied lymph node tissue. (E)
Photomicrograph shows clusters of infiltrating metastatic carcinoma cells on the right side of view (H&E, × 400).
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nodes was confirmed (Fig. 1).
Two of 7 patients were diagnosed with both
breast cancer and metastatic lymph node by core
biopsy. One of the 2 cases was crossed axillary
metastasis, i.e., breast cancer in the right breast
and a metastatic lymph node in the left axilla.
Hence, she was taken for a modified radical
mastectomy of the right breast and the con-
tralateral axillay dissection and radiotherapy. The
pathologic specimen showed positive in 14 of 19
lymph nodes. The other one patient received the
modified radical mastectomy and the ipsilateral
axillay dissection, which revealed 3 metastatic of
18 lymph nodes.
Two out of the 11 malignant pathologic results
revealed metastatic lymph nodes (Fig. 2), how-
ever, primary site could not be identified through
the mammogram, whole breast ultrasound, MRI
and whole body PET. Thus, they underwent the
axillary dissection and ipsilateral breast radio-
therapy, and a close follow-up was performed for
over 2 years.
Remaining 2 patients were diagnosed with
Hodgkin’s lymphoma and B-cell lymphoma, res-
pectively. They were treated with chemotheraphy,
and the outcomes were highly satisfactory.
In the cases of chemotheraphy or radio-
theraphy (n = 7), their follow-up ultrasound
revealed that the pathologic lymph nodes were
reduced in size and showed thinning of the
cortex (Fig. 3). The mean of maximum diameters
of lymph nodes before chemotherapy was 1.37 ±
Fig 2. A 50-year-old woman with contralateral metastatic axillary lymph node after right modified radical mastectomy 2
years ago. (A) Single enlarged axillary lymph node with eccentric cortical thickening is noted in the left axilla. The size
of the lymph node is 2.0 × 1.5 cm. (B) The ultrasonography guided large needle core biopsy shows correct sampling for
the eccentric lymph node cortex. (C) The dissected axillary lymph node shows infiltration of the metastatic carcinoma (lower
left, H&E, × 100). The lymph node parenchyma shows partial fibrosis due to previous chemotherapy. (D) The core shows
infiltration of the metastatic carcinoma (H&E, × 100).
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1.1 cm and it was reduced to 0.72 ± 1.4 cm after
the chemotherapy.
DISCUSSION
The percutaneous image-guided core biopsy
increasingly becomes an alternative to a surgical
biopsy for the histologic assessment of breast
lesions.8 Guidance for the percutaneous biopsy is
provided by stereotaxis or ultrasound. Especially,
the ultrasound-guided 14-gauge automated core
biopsy is safe, fast, accurate, and cost effective.
Advantages of ultrasound as a guidance modality
for the percutaneous biopsy include lack of
ionizing radiation, use of nondedicated equip-
ment, accessibility of all areas of the breast and
the axilla, real- time visualization of the needle,
multidirectional sampling, and low cost.9 The only
disadvantage of the ultrasound guidance is that
the lesion must be sonographically evident for
implementing the ultrasound-guided biopsy.
Therefore, we consider that the ultrasound guided
axilla lymph nodes core biopsy can also be an
alternative to the surgical biopsy for the histologic
evaluation of axilla lesions.
The axillary nodal status is a very important
factor in the preoperative staging in breast cancer
patients, and it is also crucial in the pre-op
decision to perform a sentinel node biopsy or
axillary lymph node dissection. In a majority of
cases, US-guided FNAC has been an initial
procedure to detect the lymph node metastasis in
the axilla. However, the US-guided FNAC exhibits
relatively high false negative rate (11.6% to 21.0%),3
and this is most probably due to inadequate
volume sampling, fibrosis, inflammatory reactions,
and previous radiation therapies.10 Hence, several
authors6,7 tried to replace the US-guided FNAC of
axilla lymph nodes with the large needle core
biopsy using a gun in the preoperative staging of
breast cancer patients. To our best knowledge,
previous studies performed the core biopsy by
using 16-gauge or 18-gauge needles, and there are
a few reports about the 14-gauge needle core
biopsy of the axilla lymph node.
6,11,12
In the case
of the breast core biopsy, we routinely implement
the 14-gauge needle for sampling more specimens.
However, it is undoubtful whether the more
specimens we obtain, the more precise diagnosis
is obtainable. In our series, we acquired 11 cases
of malignant pathology in the core biopsy. Except
4 patients who needed the axilla dissection for
clearing the breast cancer treatment, the axillary
dissection was unnecessary for remaining 7
patients. In cases of benign pathology in the axilla
lymph node core biopsy, there was no case to
suggest false negative results such as the progres-
sion of the lymph node size or the change of the
morphology in the ultrasound follow-up. Therefore,
we postulate that the ultrasound follow-up of
pathologically confirmed benign lymph nodes in
Fig 3. A 40-year-old woman with left modified radical mastectomy 5.5 years ago. (A) Post-op follow up ultrasonography
shows eccentric cortical thickening of the contralateral axillary lymph node, which was proved to be the metastatic lymph
node by the core biopsy using 14 gauge large needle. (B) After chemotherapy, the size of the metastatic axillary lymph
node was reduced from 15 to 8 mm in the largest dimension.
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the core biopsy is a satisfactory without any
additional imaging study or a further surgical
intervention.
Various complications of the percutaneous core
biopsy such as hemorrhage or infection have been
reported. However, there were no cases of
non-diagnostic specimens and no complications in
our 31 patients who had received the large needle
gun biopsy (14G) of axilla lymph nodes. Never-
theless, a special care should be taken for reducing
unwanted complications by fully acknowledging
detailed anatomy including vessels and nerves in
the axilla. The nerves are not usually visible on
ultrasound, while the axillary vein and artery can
easily be recognized. Since the major nerves lie
between the vein and artery, their path can be
presumed through imaging the vessels.7 Lymph
nodes, on the other hand, lie more superficially
than the neurovascular structures. Thus, proper
positioning of patients and perfect guiding by
ultrasound are highly important to avoid traumatic
injuries during the large needle core biopsy of the
axilla.
In conclusion, the US-guided large needle (14G)
core biopsy of the axilla lesion is safe and effective
for the pathological evaluation. The core biopsy
could easily be employed if suspicious lymph
nodes or mass lesions were found in the axilla.
Especially in breast cancer patients, the core
biopsy of the axilla lymph node could be an
effective alternative to surgical biopsy for the
histological diagnosis.
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